Date: 2014-06-30
Type of information: Services contract
Compound: HiSeq 2500 and consumables to develop and perform non-invasive prenatal testing (NIPT)
Company: Illumina (USA -CA) Genoma (Italy)
Therapeutic area: Technology - Services
Type agreement: services
Action mechanism:
Disease:
Details: * On June 30, 2014, Illumina announced that it has entered into an agreement with Genoma under which the company will use the HiSeq 2500 and consumables from Illumina to develop and perform non-invasive prenatal testing (NIPT). Genoma plans to perform NIPT services in Italy.
Financial terms:
Latest news:
